Patient characteristics and outcomes by GN subtype in ESRD

Clinical Journal of the American Society of Nephrology

Volumn 10, Issue 7, 2015, Pages 1170-1178

  O’Shaughnessy, Michelle M ^a   Montez Rath, Maria E ^a   Lafayette, Richard A ^a   Winkelmayer, Wolfgang C ^b  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; CREATININE; HEMOGLOBIN;

ADULT; AGED; ARTICLE; CARDIOVASCULAR MORTALITY; CAUSE OF DEATH; END STAGE RENAL DISEASE; FEMALE; FOCAL GLOMERULOSCLEROSIS; FOLLOW UP; GLOMERULONEPHRITIS; GLOMERULUS FILTRATION RATE; HEMODIALYSIS; HUMAN; IMMUNOGLOBULIN A NEPHROPATHY; KIDNEY POLYCYSTIC DISEASE; LUPUS ERYTHEMATOSUS NEPHRITIS; MAJOR CLINICAL STUDY; MALE; MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS; MEMBRANOUS GLOMERULONEPHRITIS; MORBIDITY; OUTCOME ASSESSMENT; RISK ASSESSMENT; SENSITIVITY ANALYSIS; VASCULITIS; ADVERSE EFFECTS; COMORBIDITY; COMPARATIVE STUDY; COMPLICATION; EPIDEMIOLOGY; FACTUAL DATABASE; INCIDENCE; KAPLAN MEIER METHOD; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; MIDDLE AGED; MORTALITY; PERITONEAL DIALYSIS; PROPORTIONAL HAZARDS MODEL; RETROSPECTIVE STUDY; RISK FACTOR; TIME FACTOR; TREATMENT OUTCOME; UNITED STATES;

ADULT; AGED; COMORBIDITY; DATABASES, FACTUAL; FEMALE; GLOMERULONEPHRITIS; HUMANS; INCIDENCE; KAPLAN-MEIER ESTIMATE; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; PERITONEAL DIALYSIS; PROPORTIONAL HAZARDS MODELS; RENAL DIALYSIS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME; UNITED STATES;

EID: 84936885160     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.11261114     Document Type: Article

References (29)

1. USRD System: USRDS 2013 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States, Bethesda, MD, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 2013
2. Knoop T, Vikse BE, Svarstad E, Leh S, Reisæter AV, Bjørneklett R: Mortality in patients with IgA nephropathy. Am J Kidney Dis 62: 883–890, 2013
3. Lee H, Kim DK, Oh KH, Joo KW, Kim YS, Chae DW, Kim S, Chin HJ: Mortality of IgA nephropathy patients: A single center experience over 30 years. PLoS One 7: e51225, 2012
4. Mok CC, Kwok RC, Yip PS: Effect of renal disease on the standardized mortality ratio and life expectancy of patients with systemic lupus erythematosus. Arthritis Rheum 65: 2154–2160, 2013
5. Yap DY, Tang CS, Ma MK, Lam MF, Chan TM: Survival analysis and causes of mortality in patients with lupus nephritis. Nephrol Dial Transplant 27: 3248–3254, 2012
6. Chou YH, Lien YC, Hu FC, Lin WC, Kao CC, Lai CF, Chiang WC, Lin SL, Tsai TJ, Wu KD, Chen YM: Clinical outcomes and predictors for ESRD and mortality in primary GN. Clin J Am Soc Nephrol 7: 1401–1408, 2012
7. Lee H, Kim DK, Oh KH, Joo KW, Kim YS, Chae DW, Kim S, Chin HJ: Mortality and renal outcome of primary glomerulonephritis in Korea: Observation in 1,943 biopsied cases. Am J Nephrol 37: 74–83, 2013
8. Montez-Rath ME, Winkelmayer WC, Desai M: Addressing missing data in clinical studies of kidney diseases. Clin J Am Soc Nephrol 9: 1328–1335, 2014
9. White IR, Royston P: Imputing missing covariate values for the Cox model. Stat Med 28: 1982–1998, 2009
10. van Buuren S: Flexible Imputation of Missing Data, Boca Raton, FL, Chapman and Hall/CRC Press, 2012
11. Little RJA, Rubin DB: Statistical Analysis with Missing Data, 2nd Ed., Hoboken NJ, John Wiley & Sons, 2002
12. Perrone RD, Ruthazer R, Terrin NC: Survival after end-stage renal disease in autosomal dominant polycystic kidney disease: contribution of extrarenal complications to mortality. Am J Kidney Dis 38: 777–784, 2001
13. Reule S, Sexton DJ, Solid CA, Chen SC, Collins AJ, Foley RN: ESRD from autosomal dominant polycystic kidney disease in the United States, 2001-2010. Am J Kidney Dis 64: 592–599, 2014
14. Schroijen MA, van de Luijtgaarden MW, Noordzij M, Ravani P, Jarraya F, Collart F, Prütz KG, Fogarty DG, Leivestad T, Prischl FC, Wanner C, Dekker FW, Jager KJ, Dekkers OM: Survival in dialysis patients is different between patients with diabetes as primary renal disease and patients with diabetes as a co-morbid condition. Diabetologia 56: 1949–1957, 2013
15. Komatsu H, Kikuchi M, Nakagawa H, Fukuda A, Iwakiri T, Toida T, Sato Y, Kitamura K, Fujimoto S: Long-term survival of patients with IgA nephropathy after dialysis therapy. Kidney Blood Press Res 37: 649–656, 2013
16. Romeu M, Couchoud C, Delarozière JC, Burtey S, Chiche L, Harlé JR, Gondouin B, Brunet P, Berland Y, Jourde-Chiche N: Survival of patients with ANCA-associated vasculitis on chronic dialysis: data from the French REIN registry from 2002 to 2011. QJM 107: 545–555, 2014
17. Tang W, Bose B, McDonald SP, Hawley CM, Badve SV, Boudville N, Brown FG, Clayton PA, Campbell SB, Peh CA, Johnson DW: The outcomes of patients with ESRD and ANCA-associated vasculitis in Australia and New Zealand. Clin J AmSocNephrol 8: 773–780, 2013
18. Batista PB, Lopes AA, Costa FA: Association between attributed cause of end-stage renal disease and risk of death in Brazilian patients receiving renal replacement therapy. Ren Fail 27: 651–656, 2005
19. Wolfe RA, Ashby VB, Milford EL, Ojo AO, Ettenger RE, Agodoa LY, Held PJ, Port FK: Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. N Engl J Med 341: 1725–1730, 1999
20. Chang YS, Liu CJ, Wu TH, Chaou CH, Lin KC, Ou SM, Chen TJ, Chen WS, Chou CT, Tsai CY: Survival analysis in systemic lupus erythematosus patients on maintenance dialysis: A nationwide population-based study in Taiwan. Rheumatology (Oxford) 52: 166–172, 2013
21. Siu YP, Leung KT, Tong MK, Kwan TH, Mok CC: Clinical outcomes of systemic lupus erythematosus patients undergoing continuous ambulatory peritoneal dialysis. Nephrol Dial Transplant 20: 2797–2802, 2005
22. Huang JW, Hung KY, Yen CJ, Wu KD, Tsai TJ: Systemic lupus erythematosus and peritoneal dialysis: outcomes and infectious complications. Perit Dial Int 21: 143–147, 2001
23. Sule S, Fivush B, Neu A, Furth S: Increased hospitalizations and death in patients with ESRDsecondary to lupus. Lupus 21: 1208–1213, 2012
24. Chen HA, Wang JJ, Chou CT, Chien CC, Chu CC, Sheu MJ, Lin YJ, Chen PC, Chen CH: Predictors of longterm mortality in patients with andwithout systemic lupus erythematosus onmaintenance dialysis: A comparative study. J Rheumatol 38: 2390–2394, 2011
25. Lee PT, Fang HC, Chen CL, Chiou YH, Chou KJ, Chung HM: Poor prognosis of end-stage renal disease in systemic lupus erythematosus: A cohort of Chinese patients. Lupus 12: 827–832, 2003
26. Mallett A, Tang W, Clayton PA, Stevenson S, McDonald SP, Hawley CM, Badve SV, Boudville N, Brown FG, Campbell SB, Johnson DW: End-stage kidney disease due to Alport syndrome: outcomes in 296 consecutive Australia and New Zealand Dialysis and Transplant Registry cases. Nephrol Dial Transplant 29: 2277–2286, 2014
27. Ward MM: Cardiovascular and cerebrovascular morbidity and mortality among women with end-stage renal disease attributable to lupus nephritis. Am J Kidney Dis 36: 516–525, 2000
28. Bloembergen WE, Port FK, Mauger EA, Wolfe RA: Causes of death in dialysis patients: Racial and gender differences. J AmSoc Nephrol 5: 1231–1242, 1994
29. Layton JB, Hogan SL, Jennette CE, Kenderes B, Krisher J, Jennette JC, McClellan WM: Discrepancy between Medical Evidence Form 2728 and renal biopsy for glomerular diseases. Clin J Am Soc Nephrol 5: 2046–2052, 2010